Literature DB >> 32587346

Developing a vaccine against atherosclerosis.

Göran K Hansson1, Jan Nilsson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32587346     DOI： 10.1038/s41569-020-0407-7

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  5 in total

Review 1.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

Review 2.  Immune Mechanisms of Plaque Instability.

Authors:  Teresa Gerhardt; Arash Haghikia; Philip Stapmanns; David Manuel Leistner
Journal:  Front Cardiovasc Med       Date:  2022-01-11

Review 3.  Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.

Authors:  Wei Chen; Maaike Schilperoort; Yihai Cao; Jinjun Shi; Ira Tabas; Wei Tao
Journal:  Nat Rev Cardiol       Date:  2021-11-10       Impact factor: 49.421

Review 4.  Metabolism in atherosclerotic plaques: immunoregulatory mechanisms in the arterial wall.

Authors:  Maria J Forteza; Daniel F J Ketelhuth
Journal:  Clin Sci (Lond)       Date:  2022-03-31       Impact factor: 6.876

Review 5.  Macrophages in Atheromatous Plaque Developmental Stages.

Authors:  Alexander von Ehr; Christoph Bode; Ingo Hilgendorf
Journal:  Front Cardiovasc Med       Date:  2022-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.